化合物ARS-1620 T7609
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 1698055-85-4 | ¥8,580.00 | 询底价 |
1 mL | 1698055-85-4 | ¥1,770.00 | 询底价 |
1 mg | 1698055-85-4 | ¥679.00 | 询底价 |
50 mg | 1698055-85-4 | ¥6,260.00 | 询底价 |
25 mg | 1698055-85-4 | ¥4,390.00 | 询底价 |
2 mg | 1698055-85-4 | ¥980.00 | 询底价 |
10 mg | 1698055-85-4 | ¥2,780.00 | 询底价 |
5 mg | 1698055-85-4 | ¥1,720.00 | 询底价 |
Product Introduction
Bioactivity
英文名: ARS-1620
描述: ARS-1620 是 K-RASG12C 的共价抑制剂,具有理想的药代动力学。
体内活性: ARS-1620 (200 mg/kg) induces tumor regression in a MIA-PaCa2, but not an H441, mouse xenograft model.?It also decreases tumor volume in patient-derived xenograft (PDX) mouse models expressing K-RASG12C, but not K-RASG12D or wild-type K-RAS.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 53 mg/mL (123.02 mM)
关键字: inhibit | Ras | Inhibitor | ARS 1620 | ARS1620 | ARS-1620
相关产品: EHT 1864 | (S)-AMG-510 | KRAS G12C inhibitor 32 | Salirasib | Antineoplaston A10 | Glecirasib | Garsorasib | 1588-A4 | Cysmethynil | KRAS inhibitor-9
相关库: Anti-Cancer Metabolism Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | GPCR Compound Library | Kinase Inhibitor Library | Anti-Obesity Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library
化合物ARS-1620 T7609信息由TargetMol中国为您提供,如您想了解更多关于化合物ARS-1620 T7609报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途